January 14, 2019 08:18 AM EST
Discovery

Park­er-backed can­cer sci­en­tists shine a light on an emerg­ing path­way in pan­cre­at­ic can­cer

John Carroll

Editor & Founder

A cou­ple of high-pro­file can­cer re­searchers at MD An­der­son backed by the Park­er In­sti­tute have been ex­plor­ing an ex­per­i­men­tal path­way that they be­lieve shows some …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

A rare neu­ro­log­i­cal dis­ease is Sage’s last, best hope af­ter fail­ures in de­pres­sion

No­var­tis strikes ra­dio­phar­ma deal with Ra­tio worth up to $745M

Rock­et shares promis­ing long-term re­sults from rare heart dis­ease gene ther­a­py in small study

FDA of­fers more guid­ance on de­vel­op­ing cell and gene ther­a­pies

Scot­tish biotech de­buts with ‘Tro­jan horse’ plat­form for can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times